Skip to main content
Premium Trial:

Request an Annual Quote

Santaris Raises $12M in Private Investment Round

Premium

Santaris Pharma this week announced that it has raised $12 million through the sale of convertible bonds to existing private investors and members of the company's management.

Santaris said that proceeds from the financing would primarily be used to fund the continued development of its microRNA-targeting hepatitis C drug miravirsen, which is under phase II development, as well as its pipeline of other locked nucleic acid-based therapeutic candidates.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.